Double-phase hydrogel for buccal delivery of tramadol

Drug Development and Industrial Pharmacy

Volumn 38, Issue 4, 2012, Pages 468-483

  Kamel, Rabab ^a   Mahmoud, Azza ^a   El Feky, Gina ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Abuse; Bioadhesion; Buccal; Microspheres; Pain; Tramadol HCl

Indexed keywords

CARBOMER; CHLORIDE; MICROSPHERE; NALOXONE; POLYVINYL ALCOHOL; TRAMADOL;

ADSORPTION; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; FLOW KINETICS; FUNCTIONAL STATUS; HYDROGEL; HYSTERESIS; IN VIVO STUDY; INFRARED SPECTROSCOPY; MUCOADHESION; NONHUMAN; PARTICLE SIZE; QUALITY OF LIFE; RAT; SCANNING ELECTRON MICROSCOPY; SWELLING;

ADMINISTRATION, BUCCAL; ANALGESICS, OPIOID; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; CHICKENS; CHRONIC PAIN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; MALE; MICROSPHERES; OPIOID-RELATED DISORDERS; PARTICLE SIZE; POLYVINYL ALCOHOL; RATS; RATS, WISTAR; TRAMADOL;

EID: 84857574189     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.611807     Document Type: Article

References (50)

1. Katz WA, Barkin RL. (2008). Dilemmas in chronic/persistent pain management. Am J Ther, 15:256-264.
2. Sloan P, Babul N. (2006). Extended-release opioids for the management of chronic non-malignant pain. Expert Opin Drug Deliv, 3:489-497.
3. Scott LJ, Perry CM. (2000). Tramadol: A review of its use in perioperative pain. Drugs, 60:139-176. (Pubitemid 30598822)
4. Katz WA. (2002). Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases. Curr Opin Rheumatol, 14:63-71. (Pubitemid 34059892)
5. Olin BR, Ed. 2000). Drug facts and comparisons. St. Louis, Wolters Kluwer.
6. Foda NH, El-laithy HM, Tadros MI. (2007). Implantable biodegradable sponges: Effect of interpolymer complex formation of chitosan with gelatin on the release behavior of tramadol hydrochloride. Drug Dev Ind Pharm, 33:7-17. (Pubitemid 46034145)
7. Morales ME, Ruiz MA, López G, Gallardo V. (2010). Development of oral suspensions of microparticles of ethylcellulose with tramadol. Drug Dev Ind Pharm, 36:885-892.
8. Sawicki W, Mazgalski J, Jakubowska I. (2010). Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction. Drug Dev Ind Pharm, 36:209-217.
9. Hao J, Heng PW. (2003). Buccal delivery systems. Drug Dev Ind Pharm, 29:821-832. (Pubitemid 37203684)
10. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J Control Release, 114:15-40. (Pubitemid 44128620)
11. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA et al. (2001). Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain, 91:123-130. (Pubitemid 32274181)
12. Remuñán-López C, Portero A, Vila-Jato JL, Alonso MJ. (1998). Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release, 55:143-152. (Pubitemid 28477605)
13. Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: A current status. Drug Dev Ind Pharm, 34:1246-1266.
14. Lin YH, Liang HF, Chung CK, Chen MC, Sung HW. (2005). Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials, 26:2105-2113.
15. Orienti I, Treré R, Luppi B, Bigucci F, Cerchiara T, Zuccari G et al. (2002). Hydrogels formed by crosslinked poly(vinyl alcohol) as sustained drug delivery systems. Arch Pharm (Weinheim), 335:89-93.
16. Sanli O, Ay N, Isiklan N. (2007). Release characteristics of diclofenac sodium from poly(vinyl alcohol)/sodium alginate and poly(vinyl alcohol)-grafted-poly(acrylamide)/sodium alginate blend beads. Eur J Pharm Biopharm, 65:204-214. (Pubitemid 46043423)
17. Wang LY, Gu YH, Su ZG, Ma GH. (2006). Preparation and improvement of release behavior of chitosan microspheres containing insulin. Int J Pharm, 311:187-195.
18. Vasir JK, Tambwekar K, Garg S. (2003). Bioadhesive microspheres as a controlled drug delivery system. Int j Pharm, 255:13-32. (Pubitemid 36369587)
19. Duchene D, Touchard F, Peppas NA. (1988).Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm, 14(2): 283-318.
20. Tas C, Ozkan Y, Savaser A, Baykara T. (2003). In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. Farmaco, 58:605-611. (Pubitemid 36870834)
21. A-sasutjarit R, Sirivat A, Vayumhasuwan P. (2005). Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases. Pharm Res 22(12): 2134-2140. (Pubitemid 41821593)
22. Lim F, Moss RD. (1981). Microencapsulation of living cells and tissues. j Pharm Sci, 70:351-354. (Pubitemid 11068879)
23. Needleman IG, Smales FC. (1995). In vitro assessment of bioadhesion for periodontal and buccal drug delivery. Biomaterials, 16:617-624.
24. Varshosaz J, Tavakoli N, Kheirolahi F. (2006). Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. aaps Pharmscitech, 7:E24.
25. He P, Davis S, Illum, L. (1998).In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm, 166: 75-88. (Pubitemid 28239741)
26. Azarmi S, Roa W, Löbenberg R. (2007). Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm, 328:12-21. (Pubitemid 44827563)
27. Perioli L, Ambrogi V, Rubini D, Giovagnoli S, Ricci M, Blasi P et al. (2004). Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release, 95:521-533. (Pubitemid 38340502)
28. Bentley MV, Marchetti JM, Ricardo N, Ali-Abi Z, Collett JH. (1999). Influence of lecithin on some physical chemical properties of poloxamer gels: Rheological, microscopic and in vitro permeation studies. Int J Pharm, 193:49-55.
29. Shanker G, Kumar CK, Gonugunta CS, Kumar BV, Veerareddy PR. (2009). Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. aaps Pharmscitech, 10:530-539.
30. Ammar HO, Ghorab M, El-Nahhas SA, Kamel R. (2006). Design of a transdermal delivery system for aspirin as an antithrombotic drug. Int J Pharm, 327:81-88. (Pubitemid 44667340)
31. Friggeri A, Feringa BL, van Esch J. (2004). Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator. J Control Release, 97:241-248. (Pubitemid 38759481)
32. O'Neill KA, Courtney C, Rankin R, Weissman A. (1983). An automated, high-capacity method for measuring jumping latencies on a hot-plate. J Pharmacol Methods, 10:13-18. (Pubitemid 13012397)
33. Ide S, Minami M, Ishihara K, Uhl GR, Sora I, Ikeda K. (2006). Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology, 51:651-658. (Pubitemid 44215970)
34. Bryant CD, Roberts KW, Byun JS, Fanselow MS, Evans CJ. (2006). Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice. Pharmacol Biochem Behav, 85:769-779. (Pubitemid 46149006)
35. Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. (1999). In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Release, 60:287-295. (Pubitemid 29335954)
36. Chowdary KP, Rao YS. (2004). Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull, 27:1717-1724. (Pubitemid 41701593)
37. Tang Y, Du Y, Li Y, Wang X, Hu X. (2009). A thermosensitive chitosan/poly(vinyl alcohol) hydrogel containing hydroxyapatite for protein delivery. J Biomed Mater Res a, 91:953-963.
38. Nielsen LS, Schubert L, Hansen J. (1998). Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci, 6:231-239. (Pubitemid 28473224)
39. Thongborisute J, Takeuchi H. (2008). Evaluation of mucoadhesiveness of polymers by BIACORE method and mucinparticle method. Int J Pharm, 354:204-209.
40. Ch'ng HS, Park H, Kelly P, Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci, 74:399-405. (Pubitemid 15112929)
41. Dolz-Planas M, Roldan-Garcia C, Herraez-Dominguez JV, Belda-Maximino R. (1991). Thixotropy of different concentrations of microcrystalline cellulose:sodium carboxymethyl cellulose gels. J Pharm Sci, 80:75-79.
42. Jones DS, Woolfson AD, Brown AF. (1997). Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res, 14:450-457. (Pubitemid 27205003)
43. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123-133. (Pubitemid 32288781)
44. Takka S, Rajbhandari S, Sakr A. (2001). Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur J Pharm Biopharm, 52:75-82. (Pubitemid 32594790)
45. Sasa B, Odon P, Stane S, Julijana K. (2006). Analysis of surface properties of cellulose ethers and drug release from their matrix tablets. Eur J Pharm Sci, 27:375-383. (Pubitemid 43143263)
46. Anlar S, Capan Y, Hincal AA. (1993). Physico-chemical and bioadhesive properties of polyacrylic acid polymers. Pharmazie, 48:285-287. (Pubitemid 23163922)
47. Lu MY, Borodkin S, Woodward L, Li P, Diesner C, Hernandez L et al. (1991). A polymer carrier system for taste masking of macrolide antibiotics. Pharm Res, 8:706-712.
48. Pillay V, Fassihi R. (1999). In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. J Control Release, 59:229-242. (Pubitemid 29199928)
49. Raffa RB. (1996). A novel approach to the pharmacology of analgesics. Am J Med, 101:40S-46S. (Pubitemid 26269075)
50. Raffa RB, Haslego ML, Maryanoff CA, Villani FJ, Codd EE, Connelly CD et al. (1996). Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride. J Pharmacol Exp Ther, 278:1098-1104. (Pubitemid 27166958)